New User? Sign Up | Sign In

Insider Trading - Aerovate Therapeutics Inc. (AVTE)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

AVTE Insider Trading Transactions for Aerovate Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-07-02
Purchase
2021-07-06
4:26 pm
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
Atlas Venture Associates XII L.P.
Atlas Venture Associates XII LLC
10% Owner
535,714 $14 $7,499,996 3,103,879
(Direct)
View
2021-07-01
Purchase
2021-07-06
4:27 pm
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
535,714 $14 $7,499,996 3,103,879
(Indirect
Direct)
View
2021-07-01
Purchase
2021-07-06
4:27 pm
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
357,142 $14 $4,999,988 3,758,686
(Indirect
Direct)
View
2021-07-02
Purchase
2021-07-06
4:28 pm
Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner
357,142 $14 $4,999,988 3,758,686
(Direct)
View
2021-07-02
Purchase
2021-07-06
5:03 pm
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,785,714 $14 $38,999,996 6,965,568
(Indirect)
View
2021-07-02
Purchase
2021-07-07
4:45 pm
Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
500,000 $14 $7,000,000 2,030,691
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-04-02
Option Award
2021-07-01
6:28 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
48,882 $0 48,882
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:28 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
328,921 $0 328,921
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:28 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
180,800 $0 180,800
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:29 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Eldridge George A
See Remarks
50,850 $0 50,850
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:29 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Eldridge George A
See Remarks
98,676 $0 98,676
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:29 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Eldridge George A
See Remarks
76,900 $0 76,900
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:31 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Gillies Hunter
Chief Medical Officer
16,294 $0 16,294
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:31 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Gillies Hunter
Chief Medical Officer
109,640 $0 109,640
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:31 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Gillies Hunter
Chief Medical Officer
60,300 $0 60,300
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:32 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
CEO
254,253 $0 254,253
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:32 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
CEO
493,381 $0 493,381
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:32 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
CEO
271,200 $0 271,200
(Direct)
View
2021-02-01
Option Award
2021-07-01
6:32 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
878,981 $1.893 1,874,702
(Indirect)
View
2021-02-01
Option Award
2021-07-01
6:32 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
6,102,052 $1.893 7,976,754
(Indirect)
View
2021-02-01
Option Award
2021-07-01
6:32 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
25,000 $0 25,000
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:33 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Iwicki Mark T
Director
39,550 $0 39,550
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:33 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Iwicki Mark T
Director
76,747 $0 76,747
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:33 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Iwicki Mark T
Director
42,200 $0 42,200
(Direct)
View
2021-02-01
Option Award
2021-07-01
6:34 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
1,164,213 $1.893 2,483,048
(Indirect)
View
2021-02-01
Option Award
2021-07-01
6:34 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
8,082,190 $1.893 10,565,238
(Indirect)
View
2021-02-01
Option Award
2021-07-01
6:34 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
25,000 $0 25,000
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:35 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Development Officer
16,294 $0 16,294
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:35 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Development Officer
109,640 $0 109,640
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:35 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Development Officer
26,300 $0 26,300
(Direct)
View
2021-06-29
Option Award
2021-07-01
6:36 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Resnick Joshua
Director
25,000 $0 25,000
(Direct)
View
2021-07-02
Conversion
2021-07-06
4:26 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
Atlas Venture Associates XII L.P.
Atlas Venture Associates XII LLC
10% Owner
2,568,165 $0 2,568,165
(Direct)
View
2021-07-02
Conversion
2021-07-06
4:26 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
Atlas Venture Associates XII L.P.
Atlas Venture Associates XII LLC
10% Owner
7,976,754 $0 0
(Direct)
View
2021-07-01
Conversion
2021-07-06
4:27 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
2,568,165 $0 2,568,165
(Indirect)
View
2021-07-01
Option Award
2021-07-06
4:27 pm
N/A
2031-06-30
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
2,153 $11.15 2,153
(Direct)
View
2021-07-01
Conversion
2021-07-06
4:27 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
7,976,754 $0 0
(Indirect)
View
2021-07-01
Conversion
2021-07-06
4:27 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
3,401,544 $0 3,401,544
(Indirect)
View
2021-07-01
Option Award
2021-07-06
4:27 pm
N/A
2031-06-30
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
2,467 $11.15 2,467
(Direct)
View
2021-07-01
Conversion
2021-07-06
4:27 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
10,565,238 $0 0
(Indirect)
View
2021-07-02
Conversion
2021-07-06
4:28 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner
3,401,544 $0 3,401,544
(Direct)
View
2021-07-02
Conversion
2021-07-06
4:28 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner
10,565,238 $0 0
(Direct)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,938,387 $0 4,179,854
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
987,244 $0 987,244
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
311,170 $0 311,170
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
4,000,000 $0 0
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
8,232,679 $0 0
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,066,397 $0 0
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
966,506 $0 0
(Indirect)
View
2021-07-02
Conversion
2021-07-07
4:45 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
1,530,691 $0 1,530,691
(Indirect)
View
2021-07-02
Conversion
2021-07-07
4:45 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
1,530,691 $0 0
(Indirect)
View
2021-07-15
Option Award
2021-07-19
4:28 pm
N/A
2031-07-14
Aerovate Therapeutics Inc. AVTE Dorval Allison
Director
25,000 $0 25,000
(Direct)
View